Ingredient or product comparison
Combine GHK-Cu AHK-Cu Synergy Dosing Timing: Protocol Comparison
Simultaneous Dosing (Same Injection) Hour 0 Low. CTR1 saturation limits both peptides Minimal. Neither peptide reaches optimal signaling threshold Not recommended. Receptor competition negates individual effects Split Dosing (3-Hour Gap) Hour 3 Moderate. Parti
This source-based comparison does not add ratings or recommend a winner.
- Simultaneous Dosing (Same Injection)
- Hour 0
- Low. CTR1 saturation limits both peptides
- Minimal. Neither peptide reaches optimal signaling threshold
- Not recommended. Receptor competition negates individual effects
- Split Dosing (3-Hour Gap)
- Hour 3
- Moderate. Partial overlap in plasma concentration
- Partial. GHK-Cu pathway interrupted before peak activity
- Suboptimal. Insufficient separation for independent signaling
- Staggered Dosing (6–8 Hour Gap)
- Hour 6–8
- High. Sequential receptor saturation with no overlap
- Strong. Collagen synthesis phase completes before anti-inflammatory phase begins
- Recommended. Allows each peptide to act independently at full potency
- Reverse Order (AHK-Cu First)
- Moderate. No transport competition but signaling interference
- Weak. Early NF-κB inhibition suppresses GHK-Cu's inflammatory repair cue
- Not recommended. Anti-inflammatory signal disrupts collagen pathway initiation